Rashi Aggarwal, MD, from Rutgers New Jersey Medical School, discusses screening tools and treatment options for diagnosing and managing posttraumatic stress disorder in the primary care setting.
In this podcast, David Ingram, MD, moderates a conversation with Maida Chen, MD; Pallavi Patwari, MD; Kevin Smith, PhD; Bobbi Hopkins, MD; and Michael McLeland, PhD, about how the COVID-19 pandemic is impacting pediatric sleep medicine.
In this podcast, Timothy A. Lash talks about the trends of drug pricing and how the price of drugs may contribute to medication nonadherence in the Medicare population.
In this podcast, Benjamin H. Freed, MD, answered our questions about his latest research on diffuse right ventricular fibrosis among patients with pulmonary arterial hypertension and comorbid heart failure with preserved ejection fraction.
Episode 9: Moderator Jaspal Singh, MD, MHA, MHS, interviews Susan Garwood, MD, and Nina Maouelainin, DO, MBA, about advancements in pulmonary thoracic oncology, including key innovations, important trends, and lessons learned.
In this podcast, Chuck Vega, MD, speaks about how to treat patients with community-acquired bacterial pneumonia (CABP) and how it is managed for the most common presentations, including the typical bacterial pathogens that cause CABP, the most common symptoms of CABP, treatment guidelines, and standard workup. This podcast is part 1 of a 3-part series on managing CABP.
In this podcast, Jeff Jin, PhD, discusses his team's recent study, which examined the prevalence of hepatitis C virus infection among men who have sex with men.
In this podcast, Timothy Amass, MD, answers our questions about his team's novel approach to reduce post-traumatic stress disorder and other stress-related issues for family members of patients in the intensive care unit.
In this soundbite, William Schaffner, MD, speaks about what research on school-required immunizations says about the likelihood that parents would allow children to receive a COVID-19 vaccine, even if it is considered safe and effective for children. This topic was presented at the 2021 virtual Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases.
In this podcast, Chuck Vega, MD speaks about the financial implications of various treatments for patients with community-acquired bacterial pneumonia (CABP) and for the care system. He also speaks about the decision of inpatient vs outpatient care. This podcast is part 3 of a 3-part series on managing CABP.